Jun Ishihara

Lecturer

Imperial College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jun Ishihara is a Lecturer at Imperial College London, UK. His research focuses on immunotherapy and cytokine signaling, particularly in relation to CAR T cell therapy and pancreatic cancer. Recent publications highlight advancements in vaccine technology and therapeutic strategies to mitigate immunotoxicity and cytokine release syndrome.

Articles (9)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Kevin Chang

University of Chicago

UNITED STATES

View details

Jeffrey A. Hubbell

University of Chicago

UNITED STATES

View details

Joseph Reda

New York University

UNITED STATES

View details

John Murad

Assistant Professor of Research

University of Southern California Norris Comprehensive Cancer Center

UNITED STATES

View details

Yuba Eiji

Associate Professor

Osaka University

JAPAN

View details

Eiyu Matsumoto

University of Iowa Healthcare

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jun Ishihara

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting.

The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: unravelling challenges and opportunities.

Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy

Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021

Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker.

Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin‐10 in Murine Models

Immunoengineering approaches for cytokine therapy.

Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas.

Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis

Collaborators (6)

Kevin Chang

Jeffrey A. Hubbell

Joseph Reda

John Murad

Yuba Eiji

Eiyu Matsumoto

Make your next move.